Artelo Biosciences, Inc.
ARTL· Nasdaq
ARTLArtelo Biosciences, Inc.
Filed Jan 14, 2019 · 10-Q · 45 days after period end · 0001640334-19-000036
| Metric | Q1 2019 | Q1 2018 | Q1 2017 | Q1 2016 |
|---|---|---|---|---|
| Net Income | -$556.90K | -$277.06K | -$9.52K | -$15.22K |
| EPS Diluted | -$0.32 | -$0.02 | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Artelo Biosciences, Inc. · CIK 1621221 · Engraved from SEC EDGAR
ended Nov 30, 2018 · filed Jan 14, 2019 · 45 d after period end
